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The genetic incorporation of unnatural amino acids with various side chains has 
provided a powerful tool to investigate protein structure and function. To date, more 
than 70 unnatural amino acids have been successfully incorporated into proteins by 
heterogeneous archaeal tRNA/aminoacyl-tRNA synthetase pairs in response to amber 
nonsense codon. While all genetically incorporated unnatural amino acids in cells are 
L-form, attempts to incorporate D-amino acids into proteins have only been limited to 
in  vitro  protein  synthesis.  For  instance,  D-Met  and D-Phe were incorporated  into 
proteins by modified ribosomes, and Hartman M.C. et al reported the synthesis of a 
number of peptides containing D-amino acids by utilizing  E. coli aminoacyl-tRNA 
synthetases. However, these  methods  exhibited  obvious  limitations,  such  as  low 
efficiency,  poor  yields  and  difficulty  on  scale-up.  Consequently,  it  would  be 
advantageous to incorporate D-amino acids into proteins in cells in order to study the 
roles  of  chirality  in  protein  structure  and  function,  and  to  probe  the  relationship 
between  D-amino  acids  and  pathogenetic  progression.  Typically, aminoacyl-tRNA 
synthetase  and  ribosome  prefer  L-amino  acids  for  protein  synthesis,  but  such 
specificity was suggested not to be absolute. In fact, it has been documented that a 
number of D-amino acids could be aminoacylated for the attachment to tRNA. On the 
other hand,  Pyrococcus horikoshii Lysyl-tRNA synthetase (PhLysRS) and tRNA  
orthogonal pair could utilize a amber nonsense codon to expand the genetic code in E. 
coli,[10] we  docked  the  crystal  structure  of  PhLysRS  [11] with  D-Lys  and  L-Lys 
respectively. As shown in Figure S1a, the binding packet of PhLysRS was able to well 
accommodate  D-Lys  with  more  hydrogen  bondings  than  L-Lys  (Figure  S1b), 
suggesting that PhLysRS is possibly capable of aminoacylating D-Lys. Consequently, 
this orthogonal pair was employed in the present study to explore the possibility of 



































showed  broad  substrate  specificity  primarily  responsible  for  the  cleavage  of  the 
linkage between most D-amino acids and tRNA to avoid the incorporation of D-amino 
acids  by  ribosomal  protein  synthesis  machinery,  deletion  of  the  dtd  gene  did  not 
reduce  the  toxicity  of  E.  coli K37 by various  D-amino  acids,  including  D-Lys,[8] 
suggesting  that  the  hydrolytic  activity  of D-Tyrosyl-tRNA deacylase  towards  D-
Lysyl-tRNA might be very weak. In addition, the absence of specific D-Lysyl-tRNA 
deacylase activity in E. coli further increases the possibility that D-Lysyl-tRNA could 
be stable in cells and thus permitting D-Lys to be incorporated into proteins. 
  
Figure 1.  Strategy for incorporation of D-Lys into diketoreductase by  Ph tRNA
/LysRS orthogonal pair in E. coli cells.
First, the effects of D-Lys on the growth of E. coli BL21 cells with the expression 
of  the  orthogonal Ph tRNA /LysRS pair  were  investigated because  D-Lys  was 



































single copy of Ph LysRS gene and three copies of Ph tRNA  gene to express the Ph 
tRNA / LysRS pair (Figure S2). Then, the pAC-ph△-AK3 plasmid was transformed 
into  E. coli BL21 cells and an amber codon (TAG) was changed to encode lysine. 
Different from the strong inhibition of E. coli K37 by 5 mM D-Lys,  the growth of E. 
coli cells harboring pAC-ph△-AK3 plasmid in M9 minimal medium supplemented 
with 5 mM D-Lys was surprisingly promoted (Figure 2a) compared to the control 
(Figure 2b). Figure 2c shows that D-Lys at different concentrations did not inhibit 
growth, indicating that D-Lys was not toxic to the transformed cells. Therefore, we 
postulated that the reduced toxicity of D-Lys might be due to the utilization of the 
excess amount of D-Lys by the Ph tRNA /LysRS pair to synthesize D-Lysyl-tRNA






































Figure 2. Effects of D-Lysine on the growth of engineered  E. coli cells. a) Growth 
curves of E. coli BL21 (DE3) harboring pAC-ph△-AK3 in the absence and presence 
of D-Lys. (□): M9 medium; (○): M9 medium plus 5 mM D-Lys. b) Growth curves of 
E. coli BL21 (DE3) cells in the absence and presence of D-Lys. (○): M9 medium. 
(□): M9 medium plus 5 mM D-Lys. c) Effects of various concentrations of D-Lys on 
the growth curves of E. coli cells harboring pAC-ph△-AK3 plasmid. (○): M9 medium 
plus 3.6 mM D-Lys. (□): M9 medium plus 2.4 mM D-Lys. (△): M9 medium plus 1.2 
mM D-Lys. Error bars represent standard deviations (n=3).
To verify our hypothesis, a chloramphenicol (Cm) reporting system (Figure S2a) 



































acetyltransferase (CAT) was replaced by an amber codon. [13] Since CAT cannot be 
expressed without the participation of Ph tRNA /LysRS pair, the expression of CAT 
would increase the resistance against Cm if D-Lys could be specifically utilized by Ph 
LysRS to aminoacylate with Ph tRNA . Consequently, we examined the effects of 
various concentrations of D-Lys on Cm resistance with E. coli cells harboring pAC-
ph△-AK3.  Indeed,  all  tested  concentrations  of  D-Lys  significantly  enhanced  Cm 
resistance as shown in Fig. 3. In the range of 1.2 to 3.6 mM D-Lys, the increase of Cm 
resistance was in a dose-dependent manner. These findings strongly supported that the 
Ph tRNA /LysRS pair could utilize D-Lys in the culture medium. 
Figure 3. Effects of various concentrations of D-Lys on Cm resistance of E. coli cells 
harboring pAC-ph△-AK3 plasmid. ( ):  M9 medium (IC◇ 50=120  μg.mL-1);  (○):  M9 
medium plus 1.2 mM D-Lys (IC50=180 μg.mL-1); (□): M9 medium plus 2.4 mM D-
Lys (IC50= 280  μg.mL-1); (×): M9 medium plus 5 mM D-Lys (IC50= 320  μg.mL-1); 




































To further examine whether D-Lys can be incorporated into a foreign protein in 
the cells,  we chose diketoreductasse (DKR) that has been extensively studied in our 
laboratory as a target protein. Because the Thr residue at the second position of DKR 
is located in the N-terminus [15] and any mutations at this position do not influence 
enzyme activity (data not shown), this Thr residue was selected for switching to D-
Lys. Thus, we created a pETduet-T2DK-dkr construct (Figure S2b), in which the 2nd 
codon of DKR gene was mutated from ACC to TAG. After co-transforming pETduet-
T2DK-dkr and pAC-ph△-AK3 into E. coli BL21, the resulting cells were cultured in 
M9 minimal medium containing 3.6 mM D-Lys and the mutant designated as T2DK-
DKR was  expressed  by  IPTG  induction.  Meanwhile,  the  wild-type  dkr gene  co-
transformed with the same orthogonal pair was expressed under the same conditions. 
As  expected  from  the  suppression  of  tRNA,  the  expression  level  of  T2DK-DKR 
mutant was markedly lower compared to wild-type (Figure S3). The expressed T2DK-
DKR was purified by two-step chromatography to homogeneity (Figure S4). Then, 
purified T2DK-DKR protein was hydrolyzed by acid, and the dried hydrolysate was 
derivatized and analyzed by chiral HPLC. Compared with the HPLC chromatograms 
of D-Lys and L-Lys derivatives, the derivative of D-Lys from T2DK-DKR hydrolyzate 
at 113.3 min was clearly detected and quantified as shown in Figure 4. After the same 
procedures  of  purification,  hydrolysis  and  derivatization,  wild-type  DKR  did  not 
produce the peak from the derivatization for D-Lys. Because T2DK-DKR contains 20 
Lys residues and theoretically the ratio of D- vs. L-stereoisomer should be 5.26 % if a 
D-Lys  was  completely  incorporated  into  the  protein,  our  experimental  ratio  was 
5.87±0.18% (n=3) after quantifying the peak areas in HPLC chromatograms. This 
incorporation ratio confirmed that only one D-Lys was selectively incorporated into 
T2DK-DKR protein. Although it is unclear how the protein synthesis exactly takes 
place, the remarkable increase of Cm resistance in the presence of D-Lys may provide 



































which is in an agreement with previous reports on the substrate specificity.[16] 
Figure  4. Chrial  HPLC  analysis  of  the  derivatives  of  hydrolyzates  and  Lysine 
stereoisomers. 1: Wild-type DKR; 2: T2DK mutant; 3: L-Lys; 4: D-Lys. The retention 
times of D-Lys and L- Lys derivatives were 113.3 and 122.2 min respectively.
In conclusion, we have demonstrated that the expression of Ph tRNA /LysRS pair 
could reduce the toxicity of D-Lys to  E. coli cells. Increase of Cm resistance also 
suggested that Ph LysRS could be highly stereoselective towards D-Lys in vivo when 
excess amount of D-Lys is present in the culture medium. Expression of T2DK-DKR 
mutant and analysis of D-Lys derivative by chiral HPLC further confirmed the genetic 
incorporation of D-Lys. In addition to D-Lys, the present strategy may be applicable 
to  other  D-amino  acids  by  the  genetic  manipulation  of  tRNA/aminoacyl-tRNA 
synthetase orthogonal pairs.  Moreover,  the genetic incorporation of D-amino acids 
may provide a new tool for the investigation of protein structure and function. 
Experimental Section
Briefly, all engineered E. coli cells grew in the presence of respective antibiotics. 
Cell  growth  rates  and  chloramphenicol resistance  were  determined  by 



































T2DK-dkr were  constructed  and  transformed  to  E.  coli BL21  (DE3)  cells. 
Subsequently, T2DK-DKR mutant was expressed by IPTG induction and purified by 
Nickel affinity and  anion-exchange chromatography.  Then, the purified T2DK-DKR 
mutant was hydrolyzed by 10 N HCl and  derivatized with  4-fluoro-7-nitro-2, 1, 3-
benzoxadiazole, and the derivatives of D-Lys and L-Lys were analyzed by HPLC on a 
Chiralcel OD-RH column with a gradient elution. 
(Detailed excremental procedures can be found in the Supporting information.)
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1. Experimental details 
1.1 Materials
4-Fluoro-7-nitro-2,  1,  3-benzoxadiazole (NBD-F)  was  purchased  from  Sigma 
(Sigma, USA). D-Lysine monohydrochloride was purchased from Qiude Biochemical 
Engineering  Co  (Qiude,  China).  Pyrococcus  horikoshii ATCC  700860  and 
pACYC184 plasmid  in  E.  coli  ATCC 37033  were  obtained  from American  Type 
Culture  Collection  (ATCC,  USA).  lpp-AKtRNA-rrnC  gene,  GlnRS  promoter  and 
terminator genes were synthesized according to the patent [1] and ligated to pMD-18T 
vector. pMD-18T and pETDuet-1 vectors were obtained from TaKaRa  (Japan) and 
Novagen (USA), respectively. All restriction endonucleases and T4 DNA ligase were 
purchased from Fermentas (USA) and TakaRa (Japan). HPLC analysis was performed 
on Shimadzu 2010A HT with UV detector (Japan). All other regents were purchased 
from Sigma Co. (USA). 
1.2 Sources of LysRS/ tRNA  orthogonal pair
According to previous report and patent,  [1,  2]   tRNA  from Pyrococcus horikoshii  
ATCC 700860 was synthesized by GenScript Co. (China), and Lysyl-tRNA synthetase 
was amplified from the same strain by PCR as described in 1.4.
1.3 Molecular docking of PhLysRS with D-Lys and L-Lys
  D-Lys and L-Lys were docked to active site of crystal structure of PhLysRS (PDB: 
1irx) using Discovery studio 2.5 (DS2.5). The sdf files of D- and L-Lys were obtained 



































nlm.nih.gov/pccompound).  The  crystal  structure  of PhLysRS  was  from  the  PDB 
database (http://www.pdb.org). The Libdock algorithm and default values of DS2.5 
were  used  to  dock  PhLysRS  with  D-Lys  and  L-Lys,  respectively.  The  software 
generated  100  poses  for  D-Lys  and  L-Lys,  which  were  numbered  according  to 
Libdock scores. Then, model structures were selected based on the Libdock scores 
(>50) and the maximal number of hydrogen bonding. The binding energy between 
enzyme and substrate was subsequently calculated. 
1.4 Construction and transformation of pAC-ph△-AK3 and pETDuet-T2DK-dkr.
  P. horikoshii ATCC 700860 was anaerobic cultivated in ATCC medium1915 at 95°C 
for 7 days.  The genomic DNA of  P. horikoshii  ATCC 700860 was extracted with 
TaKaRa MiniBEST DNA Extraction Kit (Japan). The Ph Lysyl-tRNA synthetase gene 
was amplified using genomic DNA from  P. horikoshii ATCC 700860 as a template 
and primers with  KpnI and PstI restriction sites (Table S1). The created  KpnI-PstI 
fragment was ligated to pMD-18T vector, and the resulting plasmid was designated as 
pMD-18T-phkrs  .Next,  to  construct  the  pAC-phkrs,  pMD-18T-phkrs was  digested 
with  KpnI and PstI,  and the resulting  phkrs fragment  was purified and ligated to 
pACYC184 digested with the same restriction enzymes. lpp-AKtRNA-rrnC gene was 
amplified  for  three  times  using  pMD-18T-trna  as a  template  and  the  primers 
consisting of three pairs of restriction sites XbaI; BamHI; EcoRI, HindIII respectively 
(Table  S1).The  three  different  aktRNA gene  fragments  were  digested  with  XbaI, 
BamHI;  BamHI, EcoRI; EcoRI,  HindIII  respectively  and  ligated  to  pETDute-1 
digested  with  the  same restriction  enzymes.  The resulting  plasmid was  named as 
pETDuet-AK3.  Subsequently,  to  construct  the  pAC-ph△-AK3,  pETDuet-Ak3  and 
pAC-phkrs  was digested  with  XbaI  and  HindIII  respectively  and  the  resulting 
AKtRNA3 fragments were ligated with pAC-phkrs fragments. 
  dkr-TAG gene fragment was amplified using pET22b (+)-dkr as a template and the 
primers  with  BamHI and  HindIII  restriction  sites  that  contain  an  amber  codon 
(TableS1). The BamHI-HindIII fragment with TAG was ligated to pMD-18T vector. 



































digested with BamHI and HindIII. The resulting dkr-TAG fragment was purified and 
ligated to pETDuet-1 vector digested with the same restriction enzymes. 
To co-transform pAC-ph△-AK3 and pETDuet-T2DK-dkr into E. coli cells, 100 ng 
pAC-ph△-AK3 and 80 ng pETDuet-T2DK-dkr was mixed with 100 μl competent E. 
coli BL21 (DE3) cells. The mixture was placed on ice for 30 min, and then heated for 
100  s  at  42°C.  Subsequently,  the  mixture  was  diluted  by  800  μl  LB  broth  and 
incubated at 37°C for 50 min; finally, the diluted mixture was spread to LB agar plate 
and cultured at 37°C for overnight. Clones were picked and culture at 5 ml LB broth 
containing 20 µg/ml chloramphenicol, 4 µg/ml tetracycline and 40 µg/ml ampicillin.
1.5 Enzyme assay for DKR and T2DK-DKR mutant 
According to the literature,[3] spectrophotometric method was used to determine the 
DKR and T2DK-DKR mutant activity on a UV-1700 array spectrophotometer ( Japan) 
whose  cell  compartment  was  maintained  at 40°C during  the  measurements  of 
absorbance  change  at  340  nm  for  the  oxidation  of NADH.  Assay  mixture 
contained 0.15 mM NADH, 0.25 mM ethyl-6-(benzyloxy)-3, 5-dioxo- hexanoate,  5–
50 mg DKR or T2DK-DKR mutant and 0.1 M potassium phosphate buffer (pH 6.0) in 
a final volume of 1.0 ml. The decrease of absorbance at 340 nm was monitored by the 
addition of enzyme. The reaction was linear in 2 min. For all assays, enzyme activity 
was defined as one unit representing the oxidation of one µmole of NADH per minute 
per milligram protein.
1.6 Expression and purification of T2DK-DKR mutant. 
E. coli BL21 (DE3) cells harboring  pAC-ph△-AK3 and pETDuet-T2DK-dkr were 
cultivated overnight in M9 medium (50 ml) containing 20 µg/ml chloramphenicol, 4 
µg/ml tetracycline and 40  µg/ml ampicillin at  37°C, then  the cultures were diluted 
into fresh M9 medium containing 3.6 mM D-Lys with an OD600 of 0.30 and incubated 
to OD600 of 0.6, T2DK-DKR mutant was expressed by addition of 200 mM IPTG at 37 
°C,  250  rpm  for  20  h. Then,  E.  coli  cells  in  200  ml  broth were  harvested  by 
centrifugation at 8000 x g for 10 min.  5g cells was diluted in 25 ml 50 mM sodium 



































(UK).  The  lysate  was  centrifuged  for  30  min  at  13,500  x  g at  4°C,  and  25mL 
supernatant was loaded to Ni-NTA column (2.0 cm × 20 cm,  Novagen, USA)  and 
static absorbed for overnight at 4 °C. The column was successively washed with 50 
mM sodium phosphate buffer (pH 8.0) containing 10 and 50 mM imidazole for 10 
and 5 column volumes respectively; then, the T2DK-DKR mutant protein was eluted 
with  100  mM imidazole  in  the  same buffer.  The  eluate  was  concentrated  with  a 
centrifugal filter device (Millipore Corp., USA). The concentrated proteins was then 
applied onto a DEAE-Sepharose  (GE Healthcare Biosciences, USA) column (2.0 cm 
×  5.0  cm) equilibrated  with 50 mM sodium  phosphate  buffer  (pH  8.0) 
containing 1 mM DTT and 5% glycerol. After equilibrium with the buffer, the column 
was eluted with 100 ml of a linear gradient (0–0.5 M NaCl). Fractions with 3 ml each 
were  collected  at  a  flow  rate  of  1.5  ml/min. Active  fractions  were  pooled, 
concentrated and desalted using the centrifugal filter device. 
1.7 Hydrolysis of DKR and T2DK-DKR and derivatization of the hydrolyzates.
  Three mg purified T2DK-DKR mutant and wild-type DKR were hydrolyzed in 30 ml 
10  N HCl at  110  °C for  20  h.  Next,  the  hydrolyzates  were  dried  up by vacuum 
evaporation, subsequently, the dried hydrolyzates were dissolved in 500 μl of 50 mM 
sodium phosphate buffer (pH8.0) and adjusted to pH 8.0 using 10 N NaOH. 
Derivatization  of  the  hydrolyzates  and  lysine  stereoisomers  was  performed 
according to the literature [4]. Briefly, 50 μl samples was mixed with 30 μl of 50 mM 
NBD-F in acetonitrile and heated at 60 °C for 5 min to complete the reaction. Then, 
920 μl of 1% acetic acid in methanol was added to the solution to stop the reaction.
1.8 Chiral HPLC analysis
Shimadzu  SCL-2010A with  autosampler  was  used  for  the  analysis.  The  HPLC 
analysis was performed on a Chiralcel OD-RH column (5 µm, 150×4.6 mm) at 10 ℃ 
with an injection volume of 20  µl  and a  flow rate  of  0.3 ml/min.  Mobile  phases 
consisted of 0.1 % TFA aqueous solution (A) and acetonitrile (B). Mobile phases were 
degassed by ultrasonic vacuum for 30 min. Elution was carried out with a gradient of 



































recorded at wavelength of 470 nm. All samples were filtered with 0.22 μm micropore 




Figure S1 Schematic views of the interactions between PhLysRS and D-Lys and L-
Lys. Lys (in red) and active site residues of  PhLysRS are indicated as sticks. The 
carbon, nitrogen, oxygen and hydrogen atoms are shown in gray, blue, red and white 
respectively. Hydrogen bondings between Lys and active site residues are displayed 
with green dashed lines. a) Interactions between D-Lys and active site residues of 



































guanido  group  of  Arg225,  and  α-amino  group  of  D-Lys  produces  two  hydrogen 
bondings with the carboxyl groups of Asp66 and Gly27 respectively.  The ε-amino 
group of D-Lys forms two hydrogen bondings with the carboxyl group of Glu41 and 
the amino group of Gly237. The binding energy between  PhLysRS and D-Lys was 
calculated to be -13.629 kJ/mol. b) Interactions between L-Lys and active site residues 
of  PhLysRS.  The  α-amino  group  of  L-Lys  forms  a  hydrogen  bonding  with  the 
carboxyl group of Asp66, and the ε-amino group of L-Lys produces two hydrogen 
bondings with the carboxyl group of Glu41. The binding energy between  PhLysRS 
and L-Lys was calculated to be -14.027 kJ/mol. 





































Figure S2. Constructed plasmid map. a. pAC-ph△-AK3. b. pETDuet-T2DK-dkr.  
Figure S3.  12% SDS-PAGE for protein expression of  T2DK-DKR mutant and wild 
type DKR in recombinant  E. coli cells after induction. Lane 1, Soluble fraction of 
T2DK-DKR mutant; Lane 2, Soluble fraction of wild type DKR; Lane 3, Whole cells 
of T2DK-DKR mutant; Lane 4, Whole cells of wild type DKR; Lane 5, Markers for 



































Figure S4. 12% SDS-PAGE for  the  purification  of  T2DK-DKR  mutant.  Lane  1, 
Purified  T2DK-DKR protein  after  DEAE- Sepharose column;  Lane 2,  T2DK-DKR 
protein after Ni-NTA column; Lane 3, Crude extract of T2DK-DKR mutant; Lane 4, 
Markers for protein molecular weight. 
3. Supplementary tables
Table S1 Primers used in this experiment.
Primer                        5' to 3'                     Restriction site
PHKRSU:  5'-CGGGGTACCATGGTTCATTGGGCCGATTATATTG-3'   KpnI
PHKRSL:  5'-ATACTGCAGTTATGAAAGCTCGTAAGTCCTCCTT-3'    PstI
AKxbaU: 5'-ATATCTAGAGGTAAGATCTCGAACGATCAAAAATAAGTGC-3'    XbaI




AKHindL:5'-CCCAAGCTTGGTTGCATGCAAAAAAAATCCTTAGCTTTCG-3'   HindIII
DKRBamHI: 5'-CGCGGATCCATGTAGGGCATCACGAATGTCACCGTTCT-3'  BamHI
DKRHindIII5'-CCCAAGCTTTCAGTACCGGTAGAAGCCCTCGCCGCTCGC-3'  HindIII
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utilization of an orthogonal Ph tRNA /Lysyl-tRNA synthetase pair. 
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